tiprankstipranks
Trending News
More News >
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Income Statement

Compare
879 Followers

Caribou Biosciences Income Statement

Last quarter (Q3 2025), Caribou Biosciences's total revenue was $2.20M, an increase of 8.60% from the same quarter last year. In Q3, Caribou Biosciences's net income was $-27.55M. See Caribou Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.99M$ 34.48M$ 13.85M$ 9.60M$ 12.36M
Gross Profit
$ 6.07M$ 30.95M$ 10.21M$ 8.61M$ -22.06M
Operating Expenses
$ 172.68M$ 147.01M$ 116.61M$ 75.59M$ 14.06M
Depreciation and Amortization
$ 3.93M$ 3.52M$ 3.64M$ 984.00K$ 900.00K
EBITDA
$ -162.69M$ -112.53M$ -95.71M$ -65.61M$ -35.21M
Operating Income
$ -166.62M$ -116.06M$ -106.40M$ -66.98M$ -36.12M
Other Income/Expenses
$ 17.50M$ 14.18M$ 7.05M$ 377.00K$ -3.00K
Pretax Income
$ -149.11M$ -101.88M$ -99.35M$ -66.60M$ -36.13M
Net Income
$ -149.10M$ -102.07M$ -99.42M$ -66.92M$ -34.31M
Per Share Metrics
Basic EPS
$ -1.65$ -1.38$ -1.64$ -1.11$ -1.24
Diluted EPS
$ -1.65$ -1.38$ -1.64$ -1.11$ -1.24
Weighted Average Shares Outstanding
90.32M 73.81M 60.80M 60.26M 27.66M
Weighted Average Shares Outstanding (Diluted)
90.32M 73.81M 60.80M 60.26M 27.66M
Currency in USD

Caribou Biosciences Earnings and Revenue History